<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="NEW YORK, NY / ACCESSWIRE / April 3, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.” data-reactid=”12″>NEW YORK, NY / ACCESSWIRE / April 3, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Tivity Health, Inc. (TVTY)” data-reactid=”13″>Tivity Health, Inc. (TVTY)
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Investors Affected : March 8, 2019 – February 19, 2020” data-reactid=”14″>Investors Affected : March 8, 2019 – February 19, 2020
A class action has commenced on behalf of certain shareholders in Tivity Health, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) following the Nutrisystem Acquisition, Tivity’s Nutrition segment faced significant operational challenges; (ii) the foregoing would foreseeably have a significant impact on Tivity’s revenues; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Shareholders may find more information at https://securitiesclasslaw.com/securities/tivity-health-inc-loss-submission-form/?id=5909&from=1” data-reactid=”16″>Shareholders may find more information at https://securitiesclasslaw.com/securities/tivity-health-inc-loss-submission-form/?id=5909&from=1
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Inovio Pharmaceuticals, Inc. (INO)” data-reactid=”17″>Inovio Pharmaceuticals, Inc. (INO)
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Investors Affected : February 14, 2020 – March 9, 2020” data-reactid=”18″>Investors Affected : February 14, 2020 – March 9, 2020
A class action has commenced on behalf of certain shareholders in Inovio Pharmaceuticals, Inc. According to a filed complaint, throughout the class period, defendants made misleading statements about the company’s development of a purported vaccine for the novel coronavirus, artificially inflating the company’s share price and resulting in significant investor losses.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Shareholders may find more information at https://securitiesclasslaw.com/securities/inovio-pharmaceuticals-inc-loss-submission-form/?id=5909&from=1” data-reactid=”20″>Shareholders may find more information at https://securitiesclasslaw.com/securities/inovio-pharmaceuticals-inc-loss-submission-form/?id=5909&from=1
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="VMware, Inc. (VMW)” data-reactid=”21″>VMware, Inc. (VMW)
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Investors Affected : March 30, 2019 – February 27, 2020” data-reactid=”22″>Investors Affected : March 30, 2019 – February 27, 2020
A class action has commenced on behalf of certain shareholders in VMware, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) VMware’s reporting with respect to its backlog of unfilled orders was not in compliance with all relevant accounting and disclosure requirements; (ii) the foregoing subjected the Company to a foreseeable risk of heightened regulatory scrutiny and/or investigation; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Shareholders may find more information at https://securitiesclasslaw.com/securities/vmware-inc-loss-submission-form/?id=5909&from=1” data-reactid=”24″>Shareholders may find more information at https://securitiesclasslaw.com/securities/vmware-inc-loss-submission-form/?id=5909&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770″ data-reactid=”26″>CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (212) 537-9430
Fax: (833) 862-7770
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SOURCE: The Gross Law Firm” data-reactid=”27″>SOURCE: The Gross Law Firm
View source version on accesswire.com:
https://www.accesswire.com/583872/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-TVTY-INO-and-VMW
Add Comment